Cross‐prevalence of migraine and bipolar disorder

Ortiz, Abigail; Cervantes, Pablo; Zlotnik, Gregorio; Velde, Caroline van de; Slaney, Claire; Garnham, Julie; Turecki, Gustavo; O′Donovan, Claire; Alda, Martin

doi:10.1111/j.1399-5618.2010.00832.x

Cited by 54 publications

(66 citation statements)

References 54 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Comorbid migraine affects nearly one in four patients with BD (293), and confers significantly increased risk for suicidal behavior, comorbid psychiatric disorders, and rapid cycling, as well as a greater number of mood episodes and lifetime hospitalizations compared to patients without migraine (293,294). The prevalence of migraine is reportedly higher in patients with BD II than in those with BD I (35% versus 19%) (293).…”

Section: Prevalence and Impactmentioning

confidence: 99%

See 1 more Smart Citation

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013

et al. 2012

Self Cite

View full text Add to dashboard Cite

Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O’Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.  Bipolar Disord 2012: 00: 000–000. © 2012 John Wiley & Sons A/S.Published by Blackwell Publishing Ltd.The Canadian Network for Mood and Anxiety Treatments published guidelines for the management of bipolar disorder in 2005, with updates in 2007 and 2009. This third update, in conjunction with the International Society for Bipolar Disorders, reviews new evidence and is designed to be used in conjunction with the previous publications.The recommendations for the management of acute mania remain largely unchanged. Lithium, valproate, and several atypical antipsychotic agents continue to be first‐line treatments for acute mania. Monotherapy with asenapine, paliperidone extended release (ER), and divalproex ER, as well as adjunctive asenapine, have been added as first‐line options.For the management of bipolar depression, lithium, lamotrigine, and quetiapine monotherapy, as well as olanzapine plus selective serotonin reuptake inhibitor (SSRI), and lithium or divalproex plus SSRI/bupropion remain first‐line options. Lurasidone monotherapy and the combination of lurasidone or lamotrigine plus lithium or divalproex have been added as a second‐line options. Ziprasidone alone or as adjunctive therapy, and adjunctive levetiracetam have been added as not‐recommended options for the treatment of bipolar depression. Lithium, lamotrigine, valproate, olanzapine, quetiapine, aripiprazole, risperidone long‐acting injection, and adjunctive ziprasidone continue to be first‐line options for maintenance treatment of bipolar disorder. Asenapine alone or as adjunctive therapy have been added as third‐line options.

show abstract

Section: Prevalence and Impactmentioning

confidence: 99%

“…The prevalence of migraine is reportedly higher in patients with BD II than in those with BD I (35% versus 19%) (293).…”

Section: Prevalence and Impactmentioning

confidence: 99%

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013

et al. 2012

Self Cite

View full text Add to dashboard Cite

show abstract

“…We found in the literature a well-established association between migraine and depression, but among the BD population it has been indicated that BD II may co-exist with migraine more often than BD I [25][26][27][28] . It has been reported by other groups that these co-occurring diseases are associated with greater dysfunction, an increased risk of suicidal behaviour and comorbid anxiety disorders 8,25 . As migraine is associated with the female gender and we have a higher percentage of women in the sample, it is possible that migraine prevalence may be, in fact, an artifact of the unequal distribution of gender.…”

Section: Discussionmentioning

confidence: 74%

Comorbidades médicas em pacientes ambulatoriais com transtorno do humor bipolar tipo I

Moreira¹,

Brietzke²,

Lafer³

2011

Rev. psiquiatr. clín.

View full text Add to dashboard Cite

Background: Bipolar disorder (BD) has been associated with high rates of general medical comorbidities (GMC) and medical risk factors. There have been scarce reports about this prevalence in Brazilian subjects with BD. Objective: Describe the prevalence of GMC in a sample of BD type I patients. Methods: Clinical records of 195 patients with BD type I were reviewed for identification of GMC. Patients with and without GMC were compared using the Mann-Whitney nonparametric test and the chi-Square test. Results: Sixty-three percent of patients had at least one medical comorbidity. The most prevalent conditions were: migraine (31.8%), hypothyroidism (24.1%), hypertension (11.3%), traumatic brain injuries (10.3%), asthma (9.7%), epilepsy (8.2%), diabetes (5.1%), stroke (2.1%) and hyperthyroidism (1%). Age and duration of illness were positively associated with the presence of GMC (p < 0.001). Discussion: In our study, in accordance with previous reports, the majority of patients presented at least one general medical disorder. The principal limitation of this study is the fact that diagnose of GMC was made based on self-report. There are scarce studies addressing GMC in the Brazilian population with BD and this report can contribute to improve diagnostic vigilance, assessment, treatment planning and decrease the burden associated with BD.

show abstract

“…[34] Ortiz ve arkadaşları ise BPB II'deki migren eştanısının, BPB I'dekinin iki katı sıklıkta olduğunu bildirmişlerdir. [35] …”

Section: Eştanıunclassified

Differences between Depression Episodes of Bipolar Disorder I and II

Kesebir¹,

İnanç²,

Yıldırım³

2013

Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychia

View full text Add to dashboard Cite

In 1975 Fieve and Dunner made the distinction between hypomania and mania as hypomania does not usually cause social and occupational impair-ment and hospitalization is not needed, moreover patients do not experience psychosis. Bipolar disorder type I is defined by the presence of manic and depressive episodes and differs from Bipolar disorder type II characterized with hipomanic and depressive episodes. Bipolar disorder type I and II do not differ in their depressive episodes. It is still point of contention whether bipolar type II is a variant of bipolar disorder type I or is positioned on the spectrum between bipolar type I and unipolar disorder. Even there are some similarities in characteristics of depressive episodes and outcome features of different bipolar disorder subtypes, there are differences that can be useful in differential diagnosis and treatment. This paper aims to focus on those differences between bipolar disorder type I and II

show abstract

Cross‐prevalence of migraine and bipolar disorder

Cited by 54 publications

References 54 publications

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013

Comorbidades médicas em pacientes ambulatoriais com transtorno do humor bipolar tipo I

Differences between Depression Episodes of Bipolar Disorder I and II

Contact Info

Product

Resources

About